Climb Bio (NASDAQ:CLYM) has announced the appointments of Edgar D. Charles as its Chief Medical Officer (CMO) and Cindy J. Driscoll, as Senior Vice President, Finance.

Fingerprint-based drug tests now used at 20+ Managed Waste Service sites in New South Wales. Results from Intelligent Bio’s system delivered in under 10 minutes on-site. From tariffs to ...

Vijay Pande, a general partner at Andreessen Horowitz who founded the firm’s a16z Bio + Health strategy, announced that he is stepping down from his role. Since its founding in 2014, a16z Bio ...

MENLO PARK, Calif., June 04, 2025--Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the appointment ...

Instil Bio (TIL) has announced the appointment of Jamie Freedman as Chief Medical Officer. Jamie Freedman is a Hematologist-Oncologist and a highly experienced biopharmaceutical executive.

On May 15, 2025, Cabaletta Bio ‘s Board of Directors approved a repricing of stock options, effective May 19, 2025, to retain and motivate employees during a critical phase. The repricing ...

BlueSphere Bio's new chief scientific officer brings decades of experience from big pharma to the Pittsburgh startup's innovative T-cell therapy programs. Airport traffic rebounds in April: Here's ...

Long Island Here’s how a bio implant stopped Long Island woman’s ‘horrific’ arthritis in its tracks: ‘This is the future’ By Alex Mitchell Published May 14, 2025, 6:18 p.m. ET ...